{"nct_id":"NCT00614393","title":"Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2007-12-24","start_date_type":"ACTUAL","primary_completion_date":"2010-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-03-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}